Amplification and detection reagents for HIV-1

Details Amplification and detection reagents for HIV-1 Amplification and detection reagents for HIV-1

2005-02-08

2005-02-08

Stucker, Jeffrey (Department: 1648)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S005000, C536S023720, C536S024320

Reexamination Certificate

active

06852491

ABSTRACT:
Oligonucleotide primer sets, probes, and combinations of the primer sets and probes are provided herein. These reagents are useful for amplifying and detecting HIV-1 target sequences in a test sample.

REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4948882 (1990-08-01), Ruth
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5142047 (1992-08-01), Summerton et al.
patent: 5185444 (1993-02-01), Summerton et al.
patent: 5210015 (1993-05-01), Gelfand et al.
patent: 5310652 (1994-05-01), Gelfand et al.
patent: 5322770 (1994-06-01), Gelfand
patent: 5399491 (1995-03-01), Kacian et al.
patent: 5424414 (1995-06-01), Mattingly
patent: 5464746 (1995-11-01), Fino
patent: 5686272 (1997-11-01), Marshall et al.
patent: 5925517 (1999-07-01), Tyagi et al.
patent: 5962665 (1999-10-01), Kroeger et al.
patent: WO92 20702 (1999-11-01), None
patent: 0146404 (2001-06-01), None
Tyagi et al. “Molecular Beacons: Probes that Fluoresce upon Hybridization” Nature Biotechnology, vol. 14, Mar. 1996, pp. 303-308.*
Whitcombe et al. “Detection of PCR products using self-probing amplicons and fluorescence” Nature Biotechnology, vol. 17, Aug. 1999, pp. 804-807.*
Abravaya, K., et al. “Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O and HIV-2” Journal of Clinical Microbiology, USA 38(3), pp. 716-723 (Feb. 2000).
Alaeus, A., et al. “Subtype-specific problems with quantification of plasma HIV-1 RNA” AIDS, Sweden 11(7), pp. 859-865 (Jun. 1997).
Brennan, C.A., et al. “Sequence of gp41env immunodominant region of HIV type 1 group O from west central Africa” AIDS Research and Human Retroviruses, USA 1;13(10), pp. 901-904 (Jul. 1997).
Brennan, C.A., et al. “Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda” AIDS, USA 11(15), pp. 1823-1832 (Dec. 1997).
Coste, J., et al. “Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma” Journal of Medical Virology, France 50(4), pp. 293-302 (Dec. 1996).
Debyser, Z., et al. “Failure to quantify viral load with two of the three commercial methods in pregnant woman harboring in HIV type 1 subtype G strain” AIDS Research and Human Retroviruses, Belgium 14(5), pp. 453-459 (Mar. 1998).
Gobbers, E., et al. “Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes” Journal of Virological Methods, Belgium 66(2), pp. 293-301 (Jul. 1997).
Hackett, J. Jr., et al. “Genetic analysis of HIV type 1 group O p 24gag sequences from Cameroon and Equatorial Guinea” AIDS Research and Human Retroviruses, USA 13(13), pp. 1155-1158 (Sep. 1997).
He, Q., et al. “Primers are decisive for sensitivity of PCR” Biotechniques, Finland 17(1):82, pp. 84, 86-87 (Jul. 1994).
Holguin, A., et al. “Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes” European Journal of Clinical Microbiology and Infectious Diseases, Spain 18(4), pp. 256-259 (Apr. 1999).
Jackson, J. B., et al. “Detection of Human Immunodeficiency Virus Type 1 (HIV-1) DNA and RNA Sequences in HIV-1 Antibody-Positive Blood Donors in Uganda by the Roche AMPLICOR Assay”, Journal of Clinical Microbiology, USA 35(4), pp. 873-876 (Apr. 1997).
Johanson, J., et al. “A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma” Journal of Virological Methods, USA 95(1-2), pp. 81-92 (Jun. 2001).
Kern, D., et al. “An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma”, Journal of Clinical Microbiology, USA 34(12), pp. 3196-3202 (Dec. 1996).
Kievits, T., et al. “NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection”, Journal of Virological Methods, The Neatherlands 35(3), pp. 273-286 (Dec. 1991).
Loussert-Ajak, I., et al. “Genetic diversity and HIV detection by polymerase chain reaction” Lancet 346(8988), pp. 912-913 (Sep. 1995).
Mulder, J., et al. “Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection”, Journal of Clinical Microbiology, USA 32(2), pp. 292-300 (Feb. 1994).
Ou, C-Y., et al. “DNA Amplification for direct Detection of HIV-1 in DNA of Peripheral Blood Mononuclear Cells”, Science 239 (4837), pp. 295-297 (Jan. 1988).
Repress, R.A., et al. “Detection of genetically diverse human immunodeficiency virus type 1 group M and O isolates by PCR”, Journal of Clinical Microbiology, USA 35(5), pp. 1284-1286 (May 1997).
Segondy, M., et al. “Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma” Journal of Clinical Microbiology, France 36(11), pp. 3372-3374 (Nov. 1998).
Swanson, P., et al. “Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 Monitor version 1.5, and Quantiplex HIV-1 RNA version 3.0” Journal of Clinical Microbiology, USA 39(3), pp. 862-870 (Mar. 2001).
Swanson, P., et al. “Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay”, Journal of Virological Methods, USA 89(1-2), pp. 97-108 (Sep. 1989).
Vandamme, A.M., et al. “Quantification of HIV-1 RNA in plasma: comparable results with eh NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test” Journal of Acquired Immune Deficiency Syndromes Belgium 13(2), pp. 127-139 (Oct. 1996).

Affiliated with

Also associated with

Rating

Amplification and detection reagents for HIV-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amplification and detection reagents for HIV-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amplification and detection reagents for HIV-1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3467157